Kalpa Pharmaceuticals Testoxyl Cypionate 250 is a testosterone cypionate injectable formulation designed to deliver stable and consistent dosing. As a long-acting ester, maintaining accurate concentration is essential for predictable performance and batch reliability.
Below is the latest independent lab test verifying the potency of Testoxyl Cypionate 250, conducted by a trusted third-party laboratory.
Latest Lab Result (2026)
Janoshik Lab Report – 2026-03-20
- Product: Testoxyl Cypionate 250
- Active Substance: Testosterone Cypionate
- Manufacturer: Kalpa Pharmaceuticals
- Labeled Dosage: 250 mg/mL
- Result: 271.46 mg/mL
- Laboratory: Janoshik
This lab test shows a measured concentration of 271.46 mg/mL, which is above the labeled 250 mg/mL dosage. This result indicates a consistent overfill, commonly used to ensure minimum potency throughout the product’s shelf life.
Potency Analysis
- Labeled dosage: 250 mg/mL
- Measured dosage: 271.46 mg/mL
- Deviation: ~+8.6%
- Laboratory: Janoshik
The measured result shows a moderate positive deviation from the labeled dosage, indicating a slightly higher concentration while remaining within a controlled range.
About Testoxyl Cypionate 250
Testosterone Cypionate is a long-acting ester widely used in injectable formulations requiring stable release. Accurate dosing is important to ensure consistent concentration levels across batches.
Independent lab testing provides verification of real-world potency and helps confirm that each batch meets expected standards.
Conclusion
The available lab test for Kalpa Pharmaceuticals Testoxyl Cypionate 250 shows a measured concentration of 271.46 mg/mL, exceeding the labeled 250 mg/mL dosage. This result indicates consistent formulation with a controlled overfill.
For additional product details and specifications, the Testoxyl Cypionate 250 product page provides further information.
Frequently Asked Questions
The lab result shows a measured concentration of 271.46 mg/mL, which is above the labeled dosage.
Moderate overfill is commonly used in injectable formulations to ensure that the product meets or exceeds its labeled potency.
The available report was conducted by Janoshik, an independent laboratory.
Currently, only one lab test is available. Additional reports may provide more insight into batch consistency.
